Kintara Therapeutics Inc [NASDAQ: KTRA] stock went on an upward path that rose over 20.67% on Tuesday, amounting to a one-week price increase of more than 13.09%.
Over the last 12 months, KTRA stock dropped by -93.98%. The one-year Kintara Therapeutics Inc stock forecast points to a potential upside of 98.43. The average equity rating for KTRA stock is currently 2.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $11.94 million, with 55.30 million shares outstanding and 55.30 million shares in the current float. Compared to the average trading volume of 14.13M shares, KTRA stock reached a trading volume of 24685337 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Kintara Therapeutics Inc [KTRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KTRA shares is $14.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KTRA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
KTRA Stock Performance Analysis:
Kintara Therapeutics Inc [KTRA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.09. With this latest performance, KTRA shares gained by 51.05% in over the last four-week period, additionally plugging by 9.09% over the last 6 months – not to mention a drop of -93.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KTRA stock in for the last two-week period is set at 53.95, with the RSI for the last a single of trading hit 53.76, and the three-weeks RSI is set at 54.28 for Kintara Therapeutics Inc [KTRA]. The present Moving Average for the last 50 days of trading for this stock 0.1695, while it was recorded at 0.1924 for the last single week of trading, and 0.9664 for the last 200 days.
Insight into Kintara Therapeutics Inc Fundamentals:
Kintara Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.04 and a Current Ratio set at 5.04.
Kintara Therapeutics Inc [KTRA] Institutonal Ownership Details
The top three institutional holders of KTRA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in KTRA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in KTRA stock with ownership which is approximately 5.8386%.
